<DOC>
	<DOCNO>NCT01818622</DOCNO>
	<brief_summary>In randomize control study investigate effect blue-blocking goggles screen ( virtual darkness therapy ) manic symptom bipolar disorder compare placebo . This 3-armed study include 2 patient-groups non-bipolar control-group . The main hypothesis virtual darkness therapy effective additive treatment mania.Other hypotheses virtual darkness therapy significant effect sleep , motor activity , circadian rhythm mood also non-bipolar control-group .</brief_summary>
	<brief_title>Virtual Darkness Additive Treatment Mania</brief_title>
	<detailed_description>Recent discovery neurophysiology show `` virtual darkness '' achievable block blue wavelength light ( Phelps , 2007 ) . A newly discover retinal photoreceptor call Intrinsically photoresponsive retinal ganglion-cell ( IpRGC ) whose fiber directly synapses suprachiasmatic nucleus ( SCN ) , respond narrow band wavelength high sensitivity 446 484 nm ( Brainard et al. , 2001 ; Berson 2007 ) . Amber tint goggles preserve normal nocturnal melatonin level light environment , mean block blue wavelength perceive virtual darkness SCN ( Kayumov , 2005 ; Sasseville , 2006 ) . In randomize control study investigate effect blue-blocking goggles screen ( virtual darkness therapy ) manic symptom bipolar disorder compare placebo . The general feasibility method research treatment evaluate . This multi-site study cover Helse Fonna Local Health Authority 's catchment area wich serve population 120000 adult . This 3-armed study include 2 patient-groups non-bipolar control-group . The main hypothesis virtual darkness therapy effective additive treatment mania.Other hypotheses virtual darkness therapy significant effect sleep , motor activity , circadian rhythm mood also non-bipolar control-group . The study may contribute develop supplement current treatment mania may also generate new hypothesis underlie pathophysiological mechanism bipolar disorder .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>PATIENT GROUPS Inpatients Diagnosis DSM IVTR Bipolar I Bipolar II disorder current manic episode verify semistructured interview MINI plus Ability comply protocol Willingness participate study Delayed write informed consent discharge Inability comply protocol Severe retinal damage , cataract corneal damage eye Daily use NSAIDS Daily use betablockers Daily use calciumantagonists NONBIPOLAR CONTROLS Written inform consent Working night shift Diagnosed bipolar disorder single manic episode Severe retinal damage , cataract corneal damage eye Daily use alcohol Daily use benzodiazepine Daily use NSAIDS Daily use betablockers Daily use calciumantagonists</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Bipolar disorder</keyword>
	<keyword>Mania</keyword>
	<keyword>Blue-blockers</keyword>
	<keyword>Virtual darkness therapy</keyword>
	<keyword>Actigraphy</keyword>
	<keyword>Randomized control trial</keyword>
</DOC>